Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing
Selvi C. Ersoy(University of California, Santa Barbara), Michael J. Mahan(University of California, Santa Barbara), Jamey D. Marth(Howard Hughes Medical Institute), Lucien Barnes(University of California, Santa Barbara), Geneva K. Tripp(University of California, Santa Barbara), John K. House(The University of Sydney), Jeffrey W. Smith(Mirati Therapeutics (United States)), Douglas M. Heithoff(University of California, Santa Barbara)
Cited by 223
Related Papers
Ligand Binding to Integrins
|Journal of Biological Chemistry|2000|1.3k
Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
|Cancer Research|2004|597
Integrin activation controls metastasis in human breast cancer
|Proceedings of the National Academy of Sciences|2001|580
Updates to the Symbol Nomenclature for Glycans guidelines
|Glycobiology|2019|478